Not applicableUnknownNCT03004040What this trial is testingProtection From Influenza: Determining the Impact of Prior InfectionWho this might be right forInfluenza Health Sciences North Research Institute 50
Not applicableStudy completedNCT01709825What this trial is testingThe Effect of Probiotics (L. Helveticus, B. Longum, and B. Bifidum) on Immune Function and Digestive HealthWho this might be right forHealthy University of Florida 583
Large-scale testing (Phase 3)UnknownNCT03530085What this trial is testingDec+Flu+Bu Conditioning Regimen for Elderly AML in CR Undergoing Allo-HSCTWho this might be right forAcute Myeloid LeukemiaAllogeneic Hematopoietic Stem Cell TransplantationConditioning+1 more Nanfang Hospital, Southern Medical University 60
Early research (Phase 1)Study completedNCT00516035What this trial is testingSingle Group Study of the Safety of and Immune Response to a Bird Flu Vaccine (H7N3) in Healthy AdultsWho this might be right forInfluenzaVirus Diseases National Institute of Allergy and Infectious Diseases (NIAID) 22
Testing effectiveness (Phase 2)Looking for participantsNCT07779408What this trial is testingStudy to Assess Safety and Immunogenicity of an Egg-based H5N8 Influenza Vaccine at Multiple Dose Levels Adjuvanted With Matrix-M in Healthy Participants 18 Years of Age and Above.Who this might be right forHealthy VolunteersInfluenza Sanofi 640
Post-approval studies (Phase 4)Study completedNCT01987349What this trial is testingT-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) - Year 1, 2009Who this might be right forInfluenza Stanford University 72
Large-scale testing (Phase 3)Study completedNCT02451358What this trial is testingStudy of a Single Dose or Two Doses of a Quadrivalent Influenza Vaccine in Subjects Aged 6 Months or Older in IndiaWho this might be right forInfluenza Sanofi Pasteur, a Sanofi Company 400
Post-approval studies (Phase 4)Study completedNCT03308825What this trial is testingSafety and Immunogenicity of Fluzone® Quadrivalent and Fluzone® High-Dose, Influenza VaccinesWho this might be right forInfluenzaFlu Sanofi Pasteur, a Sanofi Company 240
Early research (Phase 1)Study completedNCT01390025What this trial is testingSafety Study of Anti-Influenza Virus Monoclonal Antibody to Treat InfluenzaWho this might be right forInfluenza, Human Theraclone Sciences, Inc. 40
Not applicableStudy completedNCT01459276What this trial is testingEvaluate Safety and Immunogenicity of FluvalAB-like Influenza Vaccine in Non-Elderly Adult and Elderly SubjectsWho this might be right forInfluenza Fluart Innovative Vaccine Ltd, Hungary 1,206
Early research (Phase 1)Study completedNCT04603989What this trial is testingHNC042 in Healthy Chinese Subjects to Evaluate the Safety, Tolerability, and PharmacokineticsWho this might be right forInfluenza Guangzhou Henovcom Bioscience Co. Ltd. 36
Large-scale testing (Phase 3)Study completedNCT04695717What this trial is testingThis Study Was Conducted to Evaluate the Safety and Immunogenicity of IVACFLU-S Produced in Children From 6 Months to Under 18 Years Old and the Elderly Over 60 Years Old in VietnamWho this might be right forInfluenza Vietnam Military Medical University 864
Early research (Phase 1)Study completedNCT05968989What this trial is testingTrial to Evaluate the Safety, Tolerability, and Immunogenicity of a Mosaic Hexavalent Influenza Vaccine VRC-FLUMOS0116-00-VP (FluMos-v2) in Healthy AdultsWho this might be right forInfluenza National Institute of Allergy and Infectious Diseases (NIAID) 30
Testing effectiveness (Phase 2)Study completedNCT00644540What this trial is testingImmunogenicity and Safety Following a Single Dose of Influenza Vaccines in Healthy Children Who Received Either One or the Other Vaccine (an Adjuvanted Sub-unit Influenza Vaccine and a Non-adjuvanted Split Virion Influenza Vaccine) in the Previous V70P2 StudyWho this might be right forFLU Novartis Vaccines 89
Large-scale testing (Phase 3)Study completedNCT02387294What this trial is testingImmunogenicity and Tolerability Study of Fluval AB Novo Suspension for Injection for Children and AdolescentsWho this might be right forHuman Influenza Fluart Innovative Vaccine Ltd, Hungary 120
Large-scale testing (Phase 3)Study completedNCT01481454What this trial is testingStudy of a Quadrivalent Influenza Vaccine Administered Intramuscularly in Children/Adolescents and AdultsWho this might be right forInfluenza Sanofi Pasteur, a Sanofi Company 1,701
Early research (Phase 1)Study completedNCT00380237What this trial is testingSafety of and Immune Response to a Bird Flu Virus Vaccine (H9N2) in Healthy Adults (Study B)Who this might be right forInfluenzaVirus Diseases National Institute of Allergy and Infectious Diseases (NIAID) 20
Post-approval studies (Phase 4)Ended earlyNCT01690637What this trial is testingPanama and El Salvador Children's Oseltamivir StudyWho this might be right forInfluenzaHuman Influenza Centers for Disease Control and Prevention 721
Large-scale testing (Phase 3)Ended earlyNCT01014091What this trial is testingStudy to Evaluate the Safety and Immunogenicity of GSK Biological Pandemic Candidate Influenza Vaccine (H1N1) in ChildrenWho this might be right forInfluenza GlaxoSmithKline 60
Testing effectiveness (Phase 2)Study completedNCT02921997What this trial is testingH7N9 Vaccination With and Without AS03 and Unadjuvanted H3N2v Vaccination: Standard and Systems Biology AnalysesWho this might be right forAvian InfluenzaH1N1 InfluenzaInfluenza National Institute of Allergy and Infectious Diseases (NIAID) 30